CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Conjunctivitis - infective - Management
Topical chloramphenicol
- Topical chloramphenicol has a relatively broad spectrum of action against most Gram-positive and Gram-negative bacteria, and there is little evidence of bacterial resistance to it.
- If symptoms resolve within the first 5 days of treatment, continue chloramphenicol for 48 hours afterwards.
[ABPI Medicines Compendium, 2008; ABPI Medicines Compendium, 2007b; ABPI Medicines Compendium, 2007a; BNF 54, 2007]
© NHS Institute for Innovation and Improvement